Blood

Could engineered red blood cells be an effective antiviral against SARS-CoV-2?

The latest research shows immunity to COVID-19 lasts at least 8 months

A study evaluating the association between secondary bloodstream disease and acute COVID-19

A study evaluating the association between secondary bloodstream disease and acute COVID-19

The first human clinical trial will test the practicality, precision of an oxygen-sensitive liquid bandage

Study finds much lower maternal to neonatal transfer of anti-SARS-CoV-2 antibodies

A combination of new drugs improves blood glucose control and weight loss in mice

Cannabis use impairs the physiological response to stress in female rats

Secondary bloodstream infections associated with severe COVID-19

Real-time platform for monitoring the microbiological health of COVID-19 patients in ICUs